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boxyl-labeled orotidine-5'-phosphate-C14 (05P-C"4) was biosynthetically prepared essentially as described by Lieberman, Kornberg and Simms (2) . Ammonium sulfate fractionation was used in the purification of orotidylic pyrophosphorylase from yeast (3) . The yield was increased (to about 10 per cent) by the inclusion of azauridylic acid 1 (6 X 105M) in the incubation medium to inhibit any residual orotidylic decarboxylase (4) . Uniformly labeled L-aspartate-C4 was purchased from Nuclear Chicago Corporation. dl-Dihydroorotate-C1' was synthesized as previously described (5). 5-Phosphoribosylpyrophosphate (PRPP) was purchased as the magnesium salt from Sigma Chemical Corporation, converted to the sodium salt on a Dowex-50 ion exchange column, and assayed as described by Kornberg, Lieberman and Simms (6) . Orotidylic decarboxylase was purified from baker's yeast by the method of Heppel and Hilmoe (7) .
Erythrocytes were separated from approximately 25 ml of venous blood as previously described (5) . The erythrocytes were frozen and maintained at -100 C until assays for enzymatic activities were carried out on aliquots of the whole hemolysates. Pilot studies revealed no loss of enzymatic activity over a period of 1 week. Saliva obtained using paraffin stimulation was centrifuged at 25,000 X G for 30 minutes, and the supernatant was assayed for enzymatic activity.
Assay procedures
The assay procedures, established after determining the characteristics of the enzyme systems in hemolysates of circulating erythrocytes, are modifications of those described by Lieberman and associates (2 Incubations were carried out under air in the outer chamber of stoppered center-well 10-ml Erlenmeyer flasks with constant shaking at 37°C for 60 minutes. The reactions were stopped by the introduction of excess sulfuric acid and shaking was continued for 45 minutes for completion of carbon dioxide trapping in center-well hyamine base. (8) . Radioactivity was measured using a Tricarb liquid scintillation spectrometer.2 Assays for aspartate carbamyltransferase and dihydroorotase and for isolation of orotic acid were carried out as previously described (5) .
Subjects
Control studies were carried out on erythrocytes from laboratory personnel. Erythrocytes were obtained from the parents and the 3 surviving siblings (ages 16, 12 and 8) of the deceased patient with orotic aciduria. All of father and 1 of the 2 brothers of the latter subject had hyperuricemia and clinical gout.
RESULTS
Orotidylic pyrophosphorylase. Orotidylic pyrophosphorylase, previously studied as a partially purified enzyme from yeast (2, 3) , catalyzes the formation of orotidine-5'-phosphate from orotic acid and 5-phosphoribosylpyrophosphate in the presence of Mg++ (Figure 1 ). This reaction, a reversible pyrophosphorolysis, has also been studied less rigorously in experimental tumors (4) and in rat liver homogenates (9) . Studies on the characteristics of this enzyme in human erythrocyte hemolysates are summarized by the series of graphs presented in Figure 2 . The substrate concentration curve showed enzyme saturation to be attained at approximately 5 x 10-5M orotic acid. The calculated Km for orotic acid in this system was 0.4 X 10-5. Similarly the Km for PRPP was calculated to be 1.6 x 10-5, although the instability of this compound and the wide variety of competing reactions in such a crude enzyme preparation detract from the significance of this value. In dialyzed preparations, Mg++ was required with an optimal concentration of 2 X 10-3M. The pH T/ME IN MINUTES C activity curve demonstrated maximal synthesis of 05P at 7.8. The reaction was linear with time over a period of 1 hour. It is to be noted that 05P synthesis was not proportional to enzyme concentration (number of hemolyzed erythrocytes) at rates of synthesis less than 1 mumole per hour. This lack of a linear response at these extremely low rates of synthesis was also noted in studies of the orotidylic decarboxylase reaction on erythrocyte hemolysates (see below) and of dilute preparations of rat liver homogenates and partially purified yeast enzymes. The following manipulations failed to lead to a linear response in this section of the curve: use of an internal bicarbonate carrier; addition of glutathione, cysteine or human albumin; addition of a boiled extract of a hemolysate; incubation at 240 C or collecting CO2 at 560 C. In all assay procedures, determinations were made on the linear part of the enzyme concentration curve. The reversibility of this reaction in erythrocyte preparations was demonstrated as the release of orotic acid-C14 from 05P-C14 in the presence of inorganic pyrophosphate, but the characteristics of the backward reaction (pH curve, time curve, substrate concentration curve) were not determined.
Orotidylic decarboxylase. Orotidylic decarboxylase catalyzes the irreversible decarboxylation of orotidine-5'-phosphate to uridine-5'-phosphate (2). This reaction has no known cofactors. Recent evidence suggests that the activity of the enzyme is influenced by the concentration of uridine-5'-phosphate (9) , and is competitively inhibited by 6-azauridylic acid (4) . Some of the biochemical characteristics of orotidylic decarboxylase in human erythrocyte hemolysates are summarized in Figure 3 . The substrate concentration curve indicated enzyme saturation at approximately 5 X 10-5M 05P. The calculated Km for 05P is 1.1 X 10-6. There was a broad, flat pH curve with the optimal pH in the range 6.2 to 6.8. The decarboxylation was linear with time over a period of 2 hours. The enzyme concentration curve deviated from a linear response at rates of carbon dioxide liberation of less than 1 miumole per hour, as discussed concerning orotidylic pyrophosphorylase above. The reaction was not affected by ethylenediamine tetraacetic acid (10-2 M), the addition of Mg++, or preincubation of the enzyme preparation with pyridoxalphosphate (2 X 10-3 M), biotin (2 x 10-3 M), or avidin (1 U per ml).
Erythrocyte enzymatic activities in control subjects and in heterozygotes of orotic aciduria. The normal range of activity of orotidylic pyrophosphorylase per 109 erythrocytes is summarized in Figure 4 . Erythrocytes from the parents and two of the three siblings of the propositus of orotic aciduria (R. family) exhibited reductions of enzymatic activity while that of the third sibling was in the normal range. These determinations were carried out repeatedly and at varying enzyme concentrations. In the course of these studies, one subject (J.S.), chosen as an apparently normal control, was found to have consistently low levels of erythrocyte orotidylic pyrophosphorylase activity on five determinations over a period of several months. This subject was normal clinically and hematologically and was found to have a normal serum uric acid concentration. Studies of the parents and two brothers of J.S. (the S. family) revealed a tendency toward reduced activity of orotidylic pyrophosphorylase, but this was not statistically significant.
Orotidylic decarboxylase was also studied in the same subjects, and the enzyme activities per 109 erythrocytes are summarized in 3) Pyrimidine nucleotide treatment resulted in a reduction of orotic acid excretion, indicating a specificity of the therapeutic action. This finding is consistent with negative feedback control of pyrimidine biosynthesis, as demonstrated in E. coli in the classical studies of Yates and Pardee (11) . The accumulation and excretion of orotic acid by the patient is analogous to the pattern of "pyrimidine starvation" seen in E. coli mutants grown in minimal media. A less marked pattern of pyrimidine starvation in man has been suggested from studies on pernicious anemia (12) .
In the absence of blood cells or tissue from the deceased patient, studies were carried out on his surviving family members in an attempt to demonstrate a heterozygous defect. The data obtained demonstrated significant reductions of both orotidylic pyrophosphorylase and orotidylic decarboxylase activities in erythrocytes from the parents and two of the three siblings of the propositus. Both enzyme activities were normal in the third sibling. This pattern is consistent with the transmission of orotic aciduria as an autosomal recessive trait, with the deceased patient presumed to have been homozygous ( Figure 9 ). There was no close consanguinity in the family, although the parents had a common ancestor who was the grandfather of the father and the greatgrandfather of the mother. It is unlikely that the defect in the conversion of orotic acid to uridine-5'-phosphate was limited to the patient's erythropoietic system in view of his diversity of symptoms and failure of growth (1) . Gastrointestinal symptoms were prominent, suggesting involvement of intestinal epithelium, a tissue which is known to undergo rapid regeneration. Preliminary observations suggest that reduced activities of orotidylic pyrophosphorylase and orotidylic decarboxylase are found in polymorphonuclear leukocytes from heterozygotes of orotic aciduria. In the syndrome of primaquinesensitive hemolytic anemia, deficiency of glucose-6-phosphate dehydrogenase activity has been found in erythrocytes, platelets and leukocytes (13) . Recent studies have shown the enzyme defect to be present also in saliva (14) . Similarly, salivary levels of orotidylic pyrophosphorylase and orotidylic decarboxylase were found to be low in a heterozygote of orotic aciduria, although the wide range of normal values reduces the significance of this observation.
In previous studies of enzymatic abnormalities associated with human "inborn errors of metabolism," defects of single enzymes have been found, in keeping with the one gene-one enzyme hypothesis (15) . Possible exceptions to this generalization have been reported as combined deficiencies of 1)lood coagulation factors. Similarly, mutations in bacteria and Neurospora almost uniformly are specific for a single enzyme (16). In the current studies two sequential enzymes were found to be equally deficient. Specificity of these enzyme defects was indicated by finding normal erythrocyte levels of aspartate carbamyltransferase and dihydroorotase, earlier enzymes in the pyrimidine biosynthetic pathway. Studies of mixtures of hemolysates from normal and defective cells gave no evidence for the presence of an inhibitory agent. Further studies carried out in an attempt to determine whether the deficiency of one of these enzymes is more likely to be primary are reported elsewhere ( 17) .
In the course of these studies another subject (J.S.) was found whose erythrocytes have repeatedly exhibited over a period of months reduced activities of orotidylic pyrophosphorylase and orotidylic decarboxylase with levels comparable to those found in the family of the patient with orotic aciduria. Preliminary observations suggest that the defect is also demonstrable in his leukocytes. The enzyme defects were "specific" in that normal erythrocyte levels of aspartate carbamyltransferase and dihydroorotase were found. It seems probable that this subject is also heterozygous for orotic aciduria. It is to be noted, however, that no clear-cut pattern of inheritance could be demonstrated in his immediate family. No large survey has as yet been undertaken to document the true incidence of the orotic aciduric defect. The finding of another presumed heterozygote in the current small series suggests that the abnormal gene may have wide distribution. If this is so, the rarity of the syndrome of orotic aciduria suggests that the genetic defect is usually lethal in the homozygous state. It may well be asked how the propositus of orotic aciduria was able to survive with a homozygous defect in the main pathway for the de novo synthesis of pyrimidine nucleotides. An analogous mutant in E. coli (ATCC no. 11548) exhibits the "orotic aciduria syndrome" in that it accumulates orotic acid in the medium and demonstrates a block in the conversion of orotic acid to uridine-5'-phosphate ( 11, 17) . This organism fails to grow in the absence of an exogenous source of uracil or pyrimidine nucleotides. The patient 662 failed to resl)on(l to the administration of large amounts of uracil, indicating an ineffective "salvage synthesis" of pyrimidine nucleotides from free pyrimidine bases, which are liberated in nucleic acid degradation (18) . In the absence of an opportunity for direct measurements, it must be assumed that although homozygous, the patient was able to form orotidylic pyrophosphorylase and orotidylic decarboxylase in amounts sufficient for marginal survival. The phenomenon of interallele complementation in enzyme formation has recently been demonstrated in Neurospora crassa (19) and in some bacterial mutants. Here, the crossing of different mutants, each without detectable enzymatic activity, resulted in progeny with the ability to synthesize the enzyme in question. Enzyme production by interallele complementation has always resulted in levels of activity markedly reduced below those found in wild-type strains. It is possible that some such form of "genetic leakage" permitted the survival of the propositus of orotic aciduria.
The father and one brother of Subject J.R. have idiopathic hyperuricemia with typical attacks of gouty arthritis. The occurrence of a "pyrimidine disease" and of the most frequent "purine disease" in the same family is a provocative finding. The deceased patient with orotic aciduria exhibited no evident abnormality of uric acid metabolism. Subsequent studies of erythrocytes from ten subjects with idiopathic gout have failed to reveal the enzyme pattern of orotic aciduria (20) . At the present time no definite relationship of orotic aciduria to gout has been established. SUMMARY 1. Two enzymes which catalyze the conversion of orotic acid to uridine-5'-phosphate, orotidylic pyrophosphorylase and orotidylic decarboxylase, were found to be present in reproducible activities in circulating human erythrocytes. Both enzymes were also detected in saliva.
2. Reduced activities of orotidylic pyrophosphorylase and orotidylic decarboxylase were found in erythrocytes from the parent and two of the three siblings of the deceased propositus of orotic aciduria. The erythrocytes exhibited normal activities of aspartate carbamyltransferase and dihydroorotase, earlier enzymes in the l)yrillidine biosynthetic pathway.
3. The pattern of inheritance of orotic aciduria is consistent with that of an autosomal recessive trait.
4. In a small control series another heterozygote of orotic aciduria was discovered. It is suggested that the genetic disorder of orotic aciduria is usually lethal in its homozygous state.
